Report #2868862

Received Oct 27, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: Age unknown
State: —
Recovered: Unknown
Vaccinated: —
Onset: —
Days to onset: —
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
COVID19	COVID19 (COVID19 (PFIZER-BIONTECH))	PFIZER\BIONTECH	1	—	—

Symptoms (1)

Plasma cell myeloma

Symptom narrative

multiple myeloma; This is a spontaneous report received from a Consumer or other non HCP, Program ID. A female patient received BNT162b2 omicron (lp.8.1) (COMIRNATY (2025-2026 FORMULA)), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PLASMA CELL MYELOMA (medically significant), outcome "unknown", described as "multiple myeloma". Therapeutic measures were taken as a result of plasma cell myeloma. The caller mentioned that she received all of her Covid vaccines since Covid and gotten every single covid vaccines and then she developed multiple myeloma and she had stem cell transplant which reset her entire immune system. No follow-up attempts are possible. Batch/lot number is not provided, and it cannot be obtained.